Office of the Chief Accountant
Securities and Exchange Commission
100 F Street, N.E.
Washington, DC 20549
RE: Xenetic Biosciences, Inc.
Commission file # 333-178082
We have received a copy of, and are in agreement with, the statements being made by Xenetic Biosciences, Inc. in Item 4.01 of its Form 8-K dated April 9, 2014 and captioned “Changes in Registrant’s Certifying Accountant.” We agree with all statements pertaining to us.
We hereby consent to the filing of this letter as an exhibit to the foregoing report on Form 8-K.
Sincerely:
/s/ L.L. Bradford & Company, LLC
Las Vegas, Nevada
April 9, 2014